Dosage and administration
Swallow 1-3 tablets with meals, or as directed by physician.
Swallow 1-3 tablets with meals, or as directed by physician.
59528-0331-2
Calphron
Dietary Supplement
Phosphate Binder
200 Tablets
Swallow 1-3 tablets with meals, or as directed by physician.
Calphron is a dietary supplement that binds dietary phosphate. By binding with dietary phosphate, oral supplementation with calcium can reduce absorption of dietary phosphate.*
*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 197433 | calcium 169 MG Oral Tablet, as calcium acetate | PSN | 5 |
| 209010 | Calphron 667 MG Oral Tablet | PSN | 5 |
| 209010 | calcium acetate 667 MG Oral Tablet [Calphron] | SBD | 5 |
| 197433 | calcium acetate 667 MG Oral Tablet | SCD | 5 |
| 197433 | calcium acetate 667 MG (calcium 169 MG) Oral Tablet | SY | 5 |
| 209010 | Calphron 667 MG Oral Tablet | SY | 5 |
| Class | Version | Type | Effective |
|---|---|---|---|
| CALCIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bee4fa8d-8d82-423a-a0b5-40a89dd13a99 | Product name | 1 | 20250618 |
| e0d2eb29-08bd-4bba-90d1-c91c68a38767 | Product name | 4 | 20250516 |
| 30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2 | Product name | 5 | 20250304 |
| 334fe8d2-68fb-4331-a576-420e302ec069 | Product name | 7 | 20240320 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| e92765c1-be81-432a-b909-1b10777ec378 | Product name | 1 | 20190208 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 0441a8f5-3835-497c-aedd-bc78cba56b2a | Product name | 1 | 20150317 |
| 87711080-88eb-65c5-b2dd-bf99e700a372 | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59528-0331-2 | Calphron | 200 in 1 BOTTLE, PLASTIC | TABLET | 200 | 5 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59528-0331 | CALPHRON (MINERAL SUPPLEMENT CONTAINING CALCIUM ACETATE) TABLET [NEPHRO-TECH, INC.] | 5 | 1 package rows | 20160513_86f2e3d2-dbe3-400b-91cf-a4bf41db1342.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59528-0331-2 | EA - Each | 59528-0331 | aa16e9b9-11cf-43c3-83de-3d74372f755c | 1 | 2014-08-01 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM ACETATE | ACTIVE INGREDIENT | Y882YXF34X | 2 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59528-0331 | 59528-0331-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CALCIUM ACETATE | Y882YXF34X | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calcium Acetate | CALCIUM ACETATE | American Health Packaging | 2072d9f4-abb1-4699-bde5-6041dd79cad5 | 2026-09-04 | Warnings, Adverse reactions | CALCIUM ACETATE |
| calcium acetate | CALCIUM ACETATE | REMEDYREPACK INC. | 89a2ee04-1024-4a81-ba0d-a6655d529827 | 2026-09-03 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | AvPAK | 52e35dd6-db95-98e6-e063-6294a90ab801 | 2026-05-28 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | Rising Pharma Holdings, Inc. | ce650ba5-fb42-e444-e053-2a95a90a075a | 2026-05-15 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | NCS HealthCare of KY, LLC dba Vangard Labs | 7177829c-bd89-485c-b5e3-15e457e969c5 | 2026-04-17 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | Cardinal Health 107, LLC | a23b6070-eb4b-48e3-b563-8232206a6be4 | 2026-04-15 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | Major Pharmaceuticals | 9a731cdf-6488-44ca-b97f-512a0e9deab1 | 2026-03-17 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | Westminster Pharmaceuticals, LLC | 1195f5d5-db91-4b9e-86ad-be340b43d690 | 2026-02-24 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | American Health Packaging | 1090762c-eec1-4ab0-9ddc-43caa764cd0e | 2026-01-08 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | PD-Rx Pharmaceuticals, Inc. | 925918d5-9f89-4f2f-9bb9-d9c53d90bb0a | 2025-10-14 | Warnings, Adverse reactions | CALCIUM ACETATE |
| calcium acetate | CALCIUM ACETATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | d48c66a9-26fe-4e1a-a68a-88afe83fb51d | 2025-07-01 | Warnings, Adverse reactions | CALCIUM ACETATE |
| calcium acetate | CALCIUM ACETATE | AvKARE | 35a6f515-dfe7-031c-e063-6294a90a5e95 | 2025-06-04 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | Proficient Rx LP | 80c15366-9420-41c2-8817-b9c39ddfcec1 | 2025-06-01 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | Hikma Pharmaceuticals USA Inc. | 85fd41f8-2823-44ca-a15e-f1f2e5d0ff94 | 2025-04-17 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | Chartwell RX LLC | 9584350a-b6ad-45ae-b1c5-c8ca8f471c03 | 2024-10-14 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | Nivagen Pharmaceuticals, Inc. | da6dc42d-1ae6-45ff-8a81-20a7135f8d17 | 2023-12-05 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | Chartwell RX, LLC. | 781c3f1f-b622-418b-8c0e-3407e9b90656 | 2023-10-03 | Warnings, Adverse reactions | CALCIUM ACETATE |
| CALCIUM ACETATE | CALCIUM ACETATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ac4975aa-0ee9-4473-81e2-839f1556e684 | 2023-07-28 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | SQUARE PHARMACEUTICALS LIMITED | 5af79d16-31ad-4d68-9a6d-bb5d9c91535d | 2023-07-03 | Warnings, Adverse reactions | CALCIUM ACETATE |
| Calcium Acetate | CALCIUM ACETATE | Cipla USA Inc., | 000c044a-12ef-4484-942e-99552b777d58 | 2021-06-01 | Warnings, Adverse reactions | CALCIUM ACETATE |
Adverse event summaries are temporarily unavailable. Other product information remains available.